Back
United Therapeutics Stock Predictions
Sold-out (twice) tech raise for accredited investors only
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Buy
62
UTHR
United Therapeutics
Last Price:
$328.48
Seasonality Move:
7.46%
7 Day Trial
ALL ACCESS PASS
$
7
From 50,000 investors to Nasdaq? Mode's next move...
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/eliteUnited Therapeutics Stock Forecast
-
Over the next 52 weeks, United Therapeutics has on average historically risen by 18% based on the past 25 years of stock performance.
-
United Therapeutics has risen higher in 18 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 72%
-
Is United Therapeutics Stock Undervalued?The current United Therapeutics [UTHR] share price is $325.82. The Score for UTHR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
UTHR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will United Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, United Therapeutics has on average historically risen by 18% based on the past 25 years of stock performance.
United Therapeutics Stock Rating
Buy
62
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics overpriced?
-
United Therapeutics has risen higher in 18 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 72%
United Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
unither.com
52-Week Data
52-Week High:
417.82
52-Week Low:
266.98
Prediction Charts
Market Cap:
14.7B
Price in USD:
325.82
Volume:
317K
Beta:
0.53
Technical Analysis
SMA50:
302.42
SMA100:
322.82
SMA200:
342.01
52-Wk Change:
17.88%
Stock Predictions
-
Is United Therapeutics stock public?Yes, United Therapeutics is a publicly traded company.
-
What is the United Therapeutics stock quote today?The United Therapeutics stock price is 325.82 USD today.
-
How to buy United Therapeutics stock online?You can buy United Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-19 | 304.68 | 305.31 | 306.13 | 300.51 |
| May-20 | 305.87 | 309.57 | 311.99 | 304.24 |
| May-21 | 306.91 | 309.68 | 310.97 | 305.44 |
| May-22 | 308.25 | 308.72 | 310.74 | 306.16 |
| May-23 | 305.76 | 307.65 | 310.16 | 302.79 |
| May-27 | 309.34 | 314.84 | 315.87 | 307.76 |
| May-28 | 316.92 | 315.64 | 319.10 | 315.00 |
| May-29 | 315.77 | 320.37 | 320.91 | 311.62 |
| May-30 | 320.18 | 318.85 | 320.48 | 314.27 |
| Jun-2 | 317.93 | 325.48 | 327.00 | 315.56 |
| Jun-3 | 325.05 | 324.20 | 326.33 | 319.00 |
| Jun-4 | 325.00 | 323.97 | 335.00 | 323.90 |
| Jun-5 | 324.10 | 319.71 | 325.27 | 318.13 |
| Jun-6 | 322.99 | 325.82 | 326.30 | 322.60 |
United Therapeutics Earnings
United Therapeutics Earnings Report: Per Share United Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
United Therapeutics Forecast Revenue Growth
United Therapeutics Stock Analysis: Historical quarterly revenues per share for United Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.24 per share, an increase this year of $2.46 per share, and an increase next year of $1.06 per share.
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.